Tavilermide Ophthalmic Solution for the Treatment of Dry Eye
Status:
Completed
Trial end date:
2020-06-11
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of 5% tavilermide and 1%
tavilermide ophthalmic solutions compared with placebo ophthalmic solution in treating the
signs and symptoms of dry eye.